<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">JCDSA</journal-id><journal-title-group><journal-title>Journal of Cosmetics, Dermatological Sciences and Applications</journal-title></journal-title-group><issn pub-type="epub">2161-4105</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/jcdsa.2012.21006</article-id><article-id pub-id-type="publisher-id">JCDSA-18174</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Evaluation of the Behaviour of Wrinkles Fibroblasts and Normal Aged Fibroblasts in the Presence of Poly-L-Lactic Acid
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>arol</surname><given-names>Courderot-Masuyer</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Sophie</surname><given-names>Robin</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Hélène</surname><given-names>Tauzin</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Philippe</surname><given-names>Humbert</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>Bioexigence SARL, Espace Lafayette, Besan?on, France</addr-line></aff><aff id="aff2"><addr-line>INSERM UMR1098, SFR FED 4234 IBCT, Besancon, France</addr-line></aff><author-notes><corresp id="cor1">* E-mail:<email>philippe.humbert@univ-fcomte.fr(PH)</email>;</corresp></author-notes><pub-date pub-type="epub"><day>28</day><month>03</month><year>2012</year></pub-date><volume>02</volume><issue>01</issue><fpage>20</fpage><lpage>27</lpage><history><date date-type="received"><day>November</day>	<month>8th,</month>	<year>2011</year></date><date date-type="rev-recd"><day>November</day>	<month>27th,</month>	<year>2011</year>	</date><date date-type="accepted"><day>December</day>	<month>8th,</month>	<year>2011</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Background: Wrinkles are characterized by changes in the organization and structure of the dermis. Human wrinkle fibroblasts (WF) have a different functional behaviour in comparison with normal-aged fibroblasts (NF). Decreases in migration capacities and collagen I synthesis are observed. Mitochondrial function is impaired with an increase in lactate production during aging. Sculptra
  <sup>?</sup> (poly-L-lactic acid: PLLA), a biodegradable synthetic polymer, is used for subcutaneous volume restoration. Thus we decided to investigate different fibroblast functions when placed in contact with PLLA. Objectives: The potential of PLLA to compensate for the reduction of metabolic activity, to restore the migration capacity of WF and to inhibit the lactate production, was investigated and compared to NF. Methods: Two different skin samples were used from each of the three women’s facelift (one inside a face wrinkle and one from normal aged skin). Collagen I, lactate productions and proliferation capacities were investigated on monolayer cultures. Migration properties were evaluated using three-dimensional collagen lattices. Results: PLLA increased collagen I synthesis, restored migration capacities and tended to decrease lactate production in WF, whereas PPLA stimulated proliferation in NF and tended to improve the migration of NF. Conclusion: These results suggested that PLLA from Sculptra
  <sup>?</sup> acted as a stimulus for collagen production in WF and that it is suitable for correcting skin depressions, such as wrinkles. 
 
</p></abstract><kwd-group><kwd>Wrinkles; Poly-L-Lactic Acid; Collagen; Fibroblast</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Injectable Poly-L-lactic acid (PLLA) was introduced into Europe in 1999 as New-fill<sup>&#174;</sup>, receiving European Union approval to increase the volume of depressed areas, such as skin creases, wrinkles, folds and scars. In February of 2004, this indication was extended to include largevolume corrections of lipoatrophy, and in the same year it received U.S. Food and Drug Administration approval for the restoration and/or correction of the signs of facial lipoatrophy in people with human immunodeficiency virus [<xref ref-type="bibr" rid="scirp.18174-ref1">1</xref>]. Its cosmetic use was approved by the FDA in 2009 [<xref ref-type="bibr" rid="scirp.18174-ref2">2</xref>] and relies upon volumetric expansions as well as the formation of new collagen and elastic fibers. Thus, the gradual increase in dermal thickness in patients receiving PLLA injections is thought to be due to the induction of a local tissue reaction such as acute inflammatory reaction. This effect is characterized by a foreign body reaction that includes an initial increase in fibro blast activity and a subsequent progressive increase in collagen fiber deposition over the course of weeks to months [3,4]. Previous studies have demonstrated a particular behavior of WF different from that of NF. These fibroblasts populations were obtained after punch biopsies performed inside a wrinkle present on discarded tissues from a facelift and also on surrounding normal aged skin. After a comparison of these two populations of fibroblasts, a significant decrease in collagen I production and a significant impairment of migratory capacities were observed in WF compared to NF from the same patient [<xref ref-type="bibr" rid="scirp.18174-ref5">5</xref>]. Reduced synthesis of collagen I is partly responsible for the aging of the skin because it confers resistance to stresses and traction. The reduction in collagen I synthesis was also demonstrated by a lower in vitro production of type I procollagen by dermal fibroblasts isolated from skin of old versus young individuals. There is a failure to replace damaged collagen I with newly synthesized material [<xref ref-type="bibr" rid="scirp.18174-ref6">6</xref>]. To our knowledge, no study was performed in order to evaluate the effect of PLLA on the behavior of specific WF. During aging, an alteration of mitochondrial respiration is often associated with increased lactates production [<xref ref-type="bibr" rid="scirp.18174-ref7">7</xref>]. Indeed it was observed that senescent skin fibroblasts displayed higher rates of utilization of glucose and amino acids and produced more pyruvate and lactate, compared with young skin fibroblasts [<xref ref-type="bibr" rid="scirp.18174-ref8">8</xref>]. We therefore decided to investigate the effects of PLLA on the production of lactates in WF compared to NF. In the present study, the effects of PLLA (0.1% Sculptra<sup>&#174;</sup>) on proliferation, migratory capacities, collagen I and lactates production of WF compared to those of NF from the same patients were investigated.</p></sec><sec id="s2"><title>2. Materials and Methods</title><sec id="s2_1"><title>2.1. Products</title><p>Vials of dry powder of Sculptra<sup>&#174;</sup> (poly-L-Lacid acid, Sanofi aventis, France) were used in the present study. 5 ml of sterile water were added to the dry powder of Sculptra<sup>&#174; </sup>and 0.1% of this solution was added to culture medium of fibroblasts.</p></sec><sec id="s2_2"><title>2.2. Fibroblast Cultures</title><p>Punch biopsies were performed inside a wrinkle and also on surrounding normal aged skin of patients after surgical procedure. Wrinkles fibroblasts (WF) and normal aged fibroblasts (NF) were obtained from discarded tissues from three healthy female patients who had given their written consents (aged 55, 49 and 50 years old). Three fibroblast lines of WF and NF were obtained: L1 (55 years), L2 (49 years) and L3 (50 years). Cells were maintained in Dulbecco’s Modified Eagle’s Medium (DMEM) supplemented with 10% foetal calf serum (FCS) and 40 mg/ml of gentamicin and 2 mg/ml of fungizone (DMEMc). They were grown for several weeks in plastic flasks in a moist atmosphere of 5% carbon dioxin and 95% air at 37˚C. Confluent monolayers were propagated by trypsination (trypsin-EDTA 1X solution, Gibco) and replated at 1:2 dilutions. Subcultures of fibroblasts over 10 were not used.</p><p>Different groups were used for each experiment:</p><p>• NF: normal aged fibroblasts (n = 6)</p><p>• NF + PLLA (0.1% Sculptra<sup>&#174;</sup>) (n = 6)</p><p>• WF: wrinkle fibroblasts (n = 6)</p><p>• WF + PLLA (0.1% Sculptra<sup>&#174;</sup>) (n = 6)</p></sec><sec id="s2_3"><title>2.3. Fibroblasts Proliferation</title><p>Fibroblast proliferation in monolayers was assessed using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) dye-reduction assay after the action of PLLA for 24 hours, 48 hours and 72 hours. All cultures were set up in 10 wells. Fibroblasts were placed in 96-well microliter plates at a cell density of 5 &#215; 10<sup>3</sup> cells per well. After 24 hours of incubation, PLLA was added to the culture medium of WF or NF. The fibroblasts were seeded with PLLA, one for 24 hours, one for 48 hours and the final one for 72 hours. Then MTT was added. The extraction buffer was added after 4 hours. Absorbance of each well was assessed using a Multiscan Ex (Thermo, France) equipped with a 550 nm filter.</p></sec><sec id="s2_4"><title>2.4. Migratory Capacity</title><p>NF and WF were embedded in three-dimensional hydrated collagen using a modified version of the technique developed by Bell et al. [<xref ref-type="bibr" rid="scirp.18174-ref9">9</xref>]. Collagen lattices were made by mixing: six volumes of 1.76 X concentrated medium, three volumes of rat tail type I collagen solution (2 mg/ml) and one volume of fibroblast suspension (8&#183;10<sup>5</sup> cells/ml). This mixture was poured into plastic Petri dishes (60 mm diameter) (n = 10). The gel polymerized in less than 10 minutes at 37˚C. After one hour, culture medium was added and changed every 48 hours. To measure the retracted lattice diameter, the culture dishes were placed on a transparent metric scale. The measurement of the lattice diameter was taken each day for 10 days.</p></sec><sec id="s2_5"><title>2.5. Collagen I Synthesis</title><p>Fibroblasts were seeded in 12-well plates at 0.04 &#215; 10<sup>6</sup> cells per well. The plates were incubated at 37˚C with and without the presence of PLLA in DMEMc with 1% foetal calf serum for 7, 21, 30 and 42 days respectively (n = 6). The culture medium was changed twice a week. After this period, the supernatant was placed in an antiprotease solution (10% v/v, Calbiochem, France). The samples were stored at –80˚C until the analysis by Elisa method was performed. Collagen I was evaluated using murine anticollagen I monoclonal antibody (5). The antimurine second antibody was peroxidase conjugated (Sigma-Aldrich, France). Color was developed using a TMB substrate. The absorbance was read by a spectrophotometer at 620 nm (Multiscan, Thermo, France). The number of cells was counted and the amount of collagen I was expressed as &#181;g of collagen I/million of cells. Different groups were used at T = 0, 7, 21, 30 and 42 days of fibroblast cultures.</p></sec><sec id="s2_6"><title>2.6. Lactate Production</title><p>Fibroblasts were seeded in 12-wells plates at 0.04 &#215; 10<sup>6</sup> cells per well. The plates were incubated at 37˚C both with and without the presence of PLLA for 7, 21, 30 and 42 days of fibroblast cultures (n = 6). The culture medium was changed twice a week. After the incubation period, the supernatant was placed in an antiprotease solution (10%, v/v, Calbiochem, France). The samples were stored at –20˚C until the analysis. The dosage of lactates was performed by the biochemistry department of St Jacques hospital (Besan&#231;on, France) using Dimension<sup>&#210;</sup><sup> </sup>system. The oxidation of lactate in pyruvate with reduction of NAD is obtained with rabbit lacticodeshydrogenase. One molecule of NAD is transformed into one molecule of NADH for each molecule of lactate. Absorbance of NADH is proportional to the concentration of lactate and measured by spectrophotometry (340 nm). The number of cells is counted and the amount of lactates is expressed as &#181;moles of lactates/million of cells.</p></sec><sec id="s2_7"><title>2.7. Statistical Analysis</title><p>The results shown were expressed as the mean of the obtained results with the 3 cell lines (L1, L2 and L3).</p><p>The groups with PLLA and those without PLLA were compared by using one way (for cell proliferation) or two ways (for the other experiments) variance analysis followed if necessary by Fisher test. Values were considered significantly different when p &lt; 0.05.</p></sec></sec><sec id="s3"><title>3. Results</title><sec id="s3_1"><title>3.1. Cell Proliferation</title><p>The viability of NF and WF of the 3 women was higher than 80% in the presence of PLLA (0.1% of Sculptra<sup>&#174;</sup>) providing the chosen dose for the following experiments. PLLA induced a cell proliferation in NF after 72 hours of culture (<xref ref-type="fig" rid="fig1">Figure 1</xref>).</p></sec><sec id="s3_2"><title>3.2. Migration Capacity</title><p>The migration of fibroblasts was evaluated through their capacity to retract free floating collagen lattices. The retraction of collagen lattices obtained with normal aged fibroblasts depended on the time (a decrease of 68% from the initial diameter was observed at the end of 10 days). A significant difference was observed between the retraction of collagen lattices obtained with NF and WF. The cell migration was slower with WF than NF. The presence of PLLA tended to improve the retraction of collagen lattices from NF (the difference was significant for cell lines L1 and L2) suggesting a beneficial effect of PLLA on migratory capacities of NF (<xref ref-type="fig" rid="fig2">Figure 2</xref>). PLLA restored the migration capacities of WF to the same level as basal values of NF.</p></sec><sec id="s3_3"><title>3.3. Collagen I Production</title><p><xref ref-type="fig" rid="fig3">Figure 3</xref> shows the basal amount of collagen I in NF and WF groups (D0). The production of collagen I was significantly lower in WF than in NF. PLLA increased the mean production of collagen I of WF after 42 days of culture but did not modify the collagen I production of NF (<xref ref-type="fig" rid="fig4">Figure 4</xref>).</p></sec></sec></body><back><ref-list><title>References</title><ref id="scirp.18174-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">C. M. Burgess and R. M. Quiroga, “Assessment of the Safety and Efficacy of Poly-L-Lactic Acid for the Treatment of HIV-Associated Facial Lipoatrophy,” Journal of the American Academy of Dermatolology, Vol. 52, No. 2, 2005, pp. 233-239. doi:10.1016/j.jaad.2004.08.056</mixed-citation></ref><ref id="scirp.18174-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">R. Fitzgerald and D. Vleggaar, “Using Poly-L-Lactic Acid (PLLA) to Mimic Volume in Multiple Tissue Layers,” Journal of Drugs in Dermatology, Vol. 8, No. 10, 2009, pp. s5-s14.</mixed-citation></ref><ref id="scirp.18174-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">D. Vleggaar and U. Bauer, “Facial Enhancement and the European Experience with Sculptra (Poly-L-Lactic Acid),” Journal of Drugs in Dermatolology, Vol. 3, No. 5, 2004, pp. 542-547.</mixed-citation></ref><ref id="scirp.18174-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">J. K. Wildemore and D. H. Jones, “Persistent Granulomatous Inflammatory Response Injected by Injectable Poly-L-Lactic Acid for HIV Lipoatrophy,” Dermatologic Surgery, Vol. 32, No. 11, 2006, pp. 1407-1409.  
doi:10.1111/j.1524-4725.2006.32313.x</mixed-citation></ref><ref id="scirp.18174-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">M. Jouandeaud, C. Viennet, S. Bordes, B. Closs and P. Humbert, “Comparison of the Biomechanical and Biosynthetic Behavior of Normal Human Fibroblasts and Fibroblasts from Forehead Wrinkle,” IFSCC Magazine, Vol. 7, No. 2, 2004, pp. 2-6.</mixed-citation></ref><ref id="scirp.18174-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">J. Varani, M. K. Dame, L. Rittie L, S. E. Fligiel, S. Kang, G. J. Fisher and J. J. Voorhees, “Decreased Collagen Production in Chronologically Aged Skin: Roles of Age-Dependent Alteration in Fibroblast Function and Defective Mechanical Stimulation,” American Journal of Pathology, Vol. 168, No. 6, 2006, pp. 1861-1868.  
doi:10.2353/ajpath.2006.051302</mixed-citation></ref><ref id="scirp.18174-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Y. H. Wei, S. B. Wu, Y. S. Ma and H. C. Lee, “Respiratory Function Decline and DNA Mutation in Mitochondria, Oxidative Stress and Altered Gene Expression during Aging,” Chang Gung Medical Journal, Vol. 32, No. 2, 2009, pp. 113-132.</mixed-citation></ref><ref id="scirp.18174-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">W. Zwerschke, S. Mazurek, P. Stockl P, E. Hutter, E. Eigenbrodt and P. Jansen-Durr, “Metabolic Analysis of Senescent Human Fibroblasts Reveals a role for AMP in Cellular Senescence,” The Biochemical Journal, Vol. 376, No. 2, 2003, pp. 403-411. doi:10.1042/BJ20030816</mixed-citation></ref><ref id="scirp.18174-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">E. Bell, B. Ivarsson and C. Merill, “Production of a Tissue-Like Structure by Contraction of Collagen Lattices by Fibroblasts of Different Proliferative Potential in Vitro,” Proceedings of the National Academy of Sciences of the USA, Vol. 76, No. 3, 1979, pp. 1274-1278.  
doi:10.1073/pnas.76.3.1274</mixed-citation></ref><ref id="scirp.18174-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">R. M. Lavker, P. S. Zheng and G. Dong, “Morphology of Aged Skin,” Clinics in Geriatric Medicine, Vol. 5, No. 1, 1989, pp. 53-67.</mixed-citation></ref><ref id="scirp.18174-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">J. Uitto, “Connective Tissue Biochemistry of the Aging Dermis. Age-Associated Alteractions in Collagen and Elastin,” Clinics in Geriatric Medicine, Vol. 5, No. 1, 1989, pp. 127-147.</mixed-citation></ref><ref id="scirp.18174-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">J. Varani, G. J. Fisher, S. Kang and J. J. Voorhees, “Molecular Mechanisms of Intrinsic Skin Aging and Retinoid-Induced Repair and Reversal,” Journal of Investigative Dermatolology. Symposium Proceedings, Vol. 3, No. 1, 1998, pp. 57-60.</mixed-citation></ref><ref id="scirp.18174-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">B. Woerle, C. W. Hanke and G. Sattler, “Poly-L-Lactic- Acid: A Temporary Filler for Soft Tissue Augmentation,” Journal of Drugs in Dermatology, Vol. 3, No. 4, 2004, pp. 385-389.</mixed-citation></ref><ref id="scirp.18174-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">B. L. Eppley and B. Dadvand, “Injectable Soft-Tisue Fillers: Clinical Overview,” Plastic and Reconstructive Surgery, Vol. 118, No. 4, 2006, pp. 98e-106e.  
doi:10.1097/01.prs.0000232436.91409.30</mixed-citation></ref><ref id="scirp.18174-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">R. N. Sherman, “Sculptra: The New Three-Dimensional Filler,” Clinics in Plastic Surgery, Vol. 33, No. 4, 2006, pp. 539-550.  
doi:10.1016/j.cps.2006.09.001</mixed-citation></ref><ref id="scirp.18174-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">S. M. Lam, B. Azizzadeh and M. Graivier, “Injectable Poly-L-Lactic Acid (Sculptra): Technical Considerations in Soft-Tissue Contourning,” Plastic and Reconstructive Surgery, Vol. 118, No. 3, 2006, pp. 55S-63S.  
doi:10.1097/01.prs.0000234612.20611.5a</mixed-citation></ref><ref id="scirp.18174-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">S. Gogolewski, M. Jovanovic, S. M. Perren, J. G. Dillon and M. K. Hughes, “Tissue Response and in Vivo Degradation of Selected Polyhydroxyacids: Polylactides (PLA), Poly(3-hydrroxubutarate) (PHB), and Poly(3-hydroxybu- tarate-co-3-hydroxyvalearte) (PHB/VA),” Journal of Bio- medical Material Research, Vol. 27, No. 9, 1993, pp. 1135-1148. doi:10.1002/jbm.820270904</mixed-citation></ref><ref id="scirp.18174-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">D. Vleggaar, “Facial Volumetric Correction with Injectable Poly-L-Lactic Acid,” Dermatologic Surgery, Vol. 31, No. 11 Pt 2, 2005, pp. 1511-1518.</mixed-citation></ref><ref id="scirp.18174-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">P. Engelhard, G. Humble and D. Mest, “Safety of Sculptra: A Review of Clinical Data,” Journal of Cosmetic and Laser Therapy, Vol. 7, No. 3/4, 2005, pp. 201-205.  
doi:10.1080/14764170500451404</mixed-citation></ref><ref id="scirp.18174-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">T. Lombardi, J. Samson, F. Plantier, C. Husson and R. Küffer, “Orofacial Granulomas after Injection of Cosmetic Fillers. Histopathological and Clinical Study of 11 Cases,” Journal of Oral Pathology &amp; Medicine, Vol. 33, No. 2, 2004, pp. 115-120.  
doi:10.1111/j.1600-0714.2004.00194.x</mixed-citation></ref><ref id="scirp.18174-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">J. C. Dallon and H. P. Ehrlich, “A Review of Fibroblast- Populated Collagen Lattices,” Wound Repair and Regeneration, Vol. 16, No. 4, 2008, pp. 472-479.  
doi:10.1111/j.1524-475X.2008.00392.x</mixed-citation></ref><ref id="scirp.18174-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">S. Prahl, T. Kueper, T. Biernoth, Y. W?hrmann, A. Munster, M. Fürstenau, et al, “Aging Skin Is Functionally Anaerobic: Importance of Coenzyme Q10 for Anti Aging Skin Care,” BioFactors, Vol. 32, No. 1-4, 2008, pp. 245- 255. doi:10.1002/biof.5520320129</mixed-citation></ref><ref id="scirp.18174-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">H. Levinson, K. E. Koyer, G. C. Saggers and H. P. Ehrlich, “Calmodulin-Myosin Light Chain Kinase Inhibition Changes Fibroblast-Populated Collagen Lattice Contraction, Cell Migration, Focal Adhesion Formation, and Wound Contraction,” Wound Repair and Regeneration, Vol. 12, No. 5, 2004, pp. 505-511.  
doi:10.1111/j.1067-1927.2004.012502.x</mixed-citation></ref><ref id="scirp.18174-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">R. S. Adelstein, M. D. Pato, J.R. Sellers, P. de Lanerolle and M. A. Conti, “Regulation of Contractile Proteins by Reversible Phosphorylation of Myosin and Myosin Kinase,” Society of General Physiologists Series, Vol. 37, 1982, pp. 273-281. </mixed-citation></ref><ref id="scirp.18174-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">A. B. Lansdown, “Calcium: A Potential Central Regulator in Wound Healing in the Skin,” Wound Repair and Regeneration, Vol. 10, No. 5, 2002, pp. 271-285.  
doi:10.1046/j.1524-475X.2002.10502.x</mixed-citation></ref><ref id="scirp.18174-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">P. Carinci, M. Bodo, R. Evangelisti and E. Becchetti, “Involvement of the Cytoskeleton in Regulation of Collagen Synthesis and Secretion,” Italian Journal of Anatomy and Embryology, Vol. 100, Suppl. 1, 1995, pp. 65- 74.</mixed-citation></ref><ref id="scirp.18174-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">S. K. Donaldson, L. Hermansen and L. Bolles, “Differential, Direct Effects of H&lt;sup&gt;+&lt;/sup&gt; on Ca&lt;sup&gt;2+&lt;/sup&gt;-Activated Force of Skinned Fibres from the Soleus, Cardiac and Adductor Magnus Muscles of Rabbits,” Pflugers Archive, Vol. 376, No. 1, 1978, pp. 55-65. doi:10.1007/BF00585248</mixed-citation></ref><ref id="scirp.18174-ref28"><label>28</label><mixed-citation publication-type="other" xlink:type="simple">N. J. Kruse and P. Bornstein, “The Metabolic Requirements for Transcellular Movement and Secretion of Collagen,” The Journal of Biological Chemistry, Vol. 250, No. 13, 1975, pp. 4841-4847.</mixed-citation></ref><ref id="scirp.18174-ref29"><label>29</label><mixed-citation publication-type="other" xlink:type="simple">K. R. Beer and M. I. Rendon, “Use of Sculptra Mark in Esthetic Rejuvenation,” Seminars in Cutaneous Medicine and Surgery, Vol. 25, No. 3, 2006, pp. 127-131.  
doi:10.1016/j.sder.2006.06.004</mixed-citation></ref></ref-list></back></article>